[Neoadjuvant hormone therapy with total radical prostatectomy: intermediate results].
Hermans
B P
BP
Université Catholique de Louvain, Clinique Universitaire St-Luc, Service d'Urologie, Bruxelles.
Lorge
F
F
Wese
F X
FX
Opsomer
R J
RJ
Van Cangh
P J
PJ
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D005485:Flutamide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000601:surgery*; D016896:Treatment Outcome
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D005485:Flutamide; D017430:Prostate-Specific Antigen
Hormonothérapie néoadjuvante à la prostatectomie radicale totale: résultats à moyen terme.